Recognized for Global Precision Health Informatics Industry Excellence in Best Practices

DNAnexus, Inc., global provider of the leading enterprise platform for precision health data, today announced it has been recognized by Frost & Sullivan with the prestigious 2025 Technology Innovation Leadership Award for excellence in best practices within the global precision health informatics industry. This accolade highlights DNAnexus’ groundbreaking contributions to integrating and synchronizing diverse clinical, multi-omics, and real-world data to accelerate innovation in life sciences.

Frost & Sullivan Best Practices awards recognize companies each year in various regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices.

“Being recognized by Frost & Sullivan validates our efforts to lead the precision health industry with innovation and impact,” said Thomas Laur, CEO, DNAnexus. “DNAnexus has established the market standard for multi-omics advanced analytics, and we will continue to prioritize expertise, collaboration, and speed as the market becomes increasingly reliant on our platform to deliver actionable insights without compromising compliance, control or security.”

Frost & Sullivan’s rigorous evaluation process identified DNAnexus as a technology leader for its ability to make complex health data accessible, actionable, and secure. The company’s enterprise platform empowers pharmaceutical companies, biotech firms, healthcare providers, clinical diagnostics, and academic researchers to collaborate, innovate and accelerate the development of personalized treatments through scientific discovery.

“Since 2009, DNAnexus has demonstrated exceptional staying power in a space where many competitors failed to gain traction,” said Surbhi Gupta, Industry Principal at Frost & Sullivan. “A key reason for this is DNAnexus’ combination of scientific fluency, user-centered design, and strategic responsiveness that defines its brand and underpins its expansion potential. This ensures long-term momentum in an increasingly complex and competitive landscape and positions DNAnexus as a cornerstone of the precision health informatics ecosystem.”

To access the report detailing Frost and Sullivan’s evaluation of DNAnexus, click here. For more information about DNAnexus and its award-winning platform, visit https://www.dnanexus.com/.

About DNAnexus

DNAnexus, the enterprise platform for precision health data, is on a mission to accelerate the development, approval, and delivery of personalized treatments. Building on more than 15 years of bioinformatics innovation and genomics expertise, DNAnexus powers a connected data ecosystem trusted by the world’s precision health leaders. This flexible ecosystem makes omics and real-world data accessible, actionable, and secure while unlocking insights that improve patient lives. For more information, visit www.dnanexus.com or follow @DNAnexus on social media.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, collaborates with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, Frost & Sullivan has been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251022444877/en/